Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya
Etienne Gignoux, Frida Athanassiadis, Ahmed Garat Yarrow, Abdullahi Jimale, Nicole Mubuto, Carole Déglise, Denis Onsongo Mosoti, Andrew S. Azman, Matilu Mwau, Francisco Luquero, Iza Ciglenecki
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · COVID-19 epidemiological studies
There are errors in the Funding and Competing Interests statements. The correct statements are:
Funding: The study was funded by the Operational Centre of Geneva of Médecins Sans Frontières (MSF). MSF programmatic funding covered all other costs associated with the study, including transportation, accommodations, materials, and equipment. MSF provided support in the form of salaries for FA, AGY, NM, CD, AA, and IC, and indirectly provided salary support for Epicentre employees EG and FL. The funder was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript. This is indicated by the affiliation of the coauthors, and their specific roles are articulated in the ‘author contributions’ section.
Competing Interests: The authors have read the journal’s policy and have the following competing interests to declare: MSF provided support in the form of salaries for FA, AGY, NM, CD, AA, and IC, and indirectly provided salary support for Epicentre employees EG and FL. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development, or marketed products associated with this research to declare.
The reference list from the paper itself. Each links out to its DOI / PubMed record.